Evidence map›Paper›PMID 29703136›Full record

ArticleBMC genomics2018

Whole-genome sequencing of Aspergillus tubingensis G131 and overview of its secondary metabolism potential.

Elodie Choque, Christophe Klopp, Sophie Valiere, José Raynal, Florence Mathieu

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A Mad7 System for Genetic Engineering of Filamentous Fungi.Journal of fungi (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Unraveling the Genome Sequence of Plant Growth PromotingJournal of fungi (Basel, Switzerland) · 2022
    Article
  9. Genomic Analysis and Assessment of Melanin Synthesis inJournal of fungi (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Elodie ChoqueUniversité de Toulouse, Laboratoire de Génie Chimique, UMR 5503 CNRS/INPT/UPS, INP-ENSAT, 1, avenue de l'Agrobiopôle, 31326, Castanet-Tolosan, France.
Christophe KloppPlate-forme Genotoul Bioinfo, UR875 Biométrie et Intelligence Artificielle, Institut National de la Recherche Agronomique, Castanet-Tolosan, France.
Sophie ValiereINRA, US 1426, GeT-PlaGe, Genotoul, Castanet-Tolosan, France.
José RaynalUniversité de Toulouse, Laboratoire de Génie Chimique, UMR 5503 CNRS/INPT/UPS, INP-ENSAT, 1, avenue de l'Agrobiopôle, 31326, Castanet-Tolosan, France.
Florence MathieuUniversité de Toulouse, Laboratoire de Génie Chimique, UMR 5503 CNRS/INPT/UPS, INP-ENSAT, 1, avenue de l'Agrobiopôle, 31326, Castanet-Tolosan, France. florence.mathieu@ensat.fr.
École Nationale Supérieure Agronomique de Toulouse · FRLaboratoire de Génie Chimique · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlack Aspergilli represent one of the most important fungal resources of primary and secondary metabolites for biotechnological industry. Having several black Aspergilli sequenced genomes should allow targeting the production of certain metabolites with bioactive properties.

resultsIn this study, we report the draft genome of a black Aspergilli, A. tubingensis G131, isolated from a French Mediterranean vineyard. This 35 Mb genome includes 10,994 predicted genes. A genomic-based discovery identifies 80 secondary metabolites biosynthetic gene clusters. Genomic sequences of these clusters were blasted on 3 chosen black Aspergilli genomes: A. tubingensis CBS 134.48, A. niger CBS 513.88 and A. kawachii IFO 4308. This comparison highlights different levels of clusters conservation between the four strains. It also allows identifying seven unique clusters in A. tubingensis G131. Moreover, the putative secondary metabolites clusters for asperazine and naphtho-gamma-pyrones production were proposed based on this genomic analysis. Key biosynthetic genes required for the production of 2 mycotoxins, ochratoxin A and fumonisin, are absent from this draft genome. Even if intergenic sequences of these mycotoxins biosynthetic pathways are present, this could not lead to the production of those mycotoxins by A. tubingensis G131.

conclusionsFunctional and bioinformatics analyses of A. tubingensis G131 genome highlight its potential for metabolites production in particular for TAN-1612, asperazine and naphtho-gamma-pyrones presenting antioxidant, anticancer or antibiotic properties.

Indexed as

Secondary MetabolismAspergillusFarmsFungal ProteinsGenome SizeIndolesMolecular Sequence AnnotationPhylogenyPiperazinesWhole Genome SequencingasperazineFungal ProteinsIndolesPiperazinesAspergillus tubingensisBlack aspergilliGenomicsSecondary metabolism

Identifiers

PMID29703136
PMCPMC6389250
OpenAlexW2790309369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.